These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24790623)

  • 21. Comparison of
    Safigholi H; Meigooni AS; Song WY
    Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the relative biological effectiveness of low energy electronic brachytherapy sources in breast tissue: a Monte Carlo study.
    White SA; Reniers B; de Jong EE; Rusch T; Verhaegen F
    Phys Med Biol; 2016 Jan; 61(1):383-99. PubMed ID: 26674746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of brachytherapy lung implant dose distributions from photon-emitting sources due to tissue heterogeneities.
    Yang Y; Rivard MJ
    Med Phys; 2011 Nov; 38(11):5857-62. PubMed ID: 22047349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
    Currier B; Munro JJ; Medich DC
    Med Phys; 2013 Aug; 40(8):080701. PubMed ID: 23927294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
    Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
    Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Aug; 37(8):4038-45. PubMed ID: 20879565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of bone dose arising from skin cancer brachytherapy: A comparison between
    Sheikholeslami S; Khodaverdian S; Hashemzaei F; Ghobadi P; Ghorbani M; Farhood B
    Comput Methods Programs Biomed; 2021 Jun; 205():106089. PubMed ID: 33862569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microdosimetric Evaluation of Current and Alternative Brachytherapy Sources-A Geant4-DNA Simulation Study.
    Famulari G; Pater P; Enger SA
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):270-277. PubMed ID: 29102279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Monte Carlo investigation of the dose distribution for
    Badry H; Oufni L; Ouabi H; Hirayama H
    Appl Radiat Isot; 2018 Jun; 136():104-110. PubMed ID: 29494942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of (101)Rh as a brachytherapy source.
    Pakravan D; Ghorbani M; Meigooni AS
    J Contemp Brachytherapy; 2015 Apr; 7(2):171-80. PubMed ID: 26034499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A revised dosimetric characterization of the model S700 electronic brachytherapy source containing an anode-centering plastic insert and other components not included in the 2006 model.
    Hiatt JR; Davis SD; Rivard MJ
    Med Phys; 2015 Jun; 42(6):2764-76. PubMed ID: 26127029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic evaluation of the dose-rate constant determined by photon spectrometry for 21 different models of low-energy photon-emitting brachytherapy sources.
    Chen ZJ; Nath R
    Phys Med Biol; 2010 Oct; 55(20):6089-104. PubMed ID: 20871136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shielding effects of metallic encapsulations and radiographic contrast agents for catheter-based intravascular brachytherapy.
    Nath R; Yue N
    Cardiovasc Radiat Med; 2001; 2(2):93-103. PubMed ID: 11340013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
    Mille MM; Xu XG; Rivard MJ
    Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in dose with segmentation of breast tissues in Monte Carlo calculations for low-energy brachytherapy.
    Sutherland JG; Thomson RM; Rogers DW
    Med Phys; 2011 Aug; 38(8):4858-65. PubMed ID: 21928657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of off-centering on dose uniformity along and around blood vessels undergoing catheter-based intravascular brachytherapy.
    Nath R; Yue N
    Cardiovasc Radiat Med; 2004; 5(2):88-96. PubMed ID: 15464946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy.
    Wang R; Li XA
    Med Phys; 2000 Nov; 27(11):2528-35. PubMed ID: 11128305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.